retatrutide weight loss efficacy New Phase 3 data just dropped 👀 Eli Lilly's trial reported average approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Lilly's triple agonist, retatrutide, delivered

Resistance training addresses both concerns simultaneously by applying mechanical load to both muscles and bones

Monitoring your reaction to either medication ensures safe and effective treatment

The Weight Watchers difference: At 6 months, our Med+ members on the GLP-1 Success Program lost 27 lbs, on average.^ ^Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program

If TRIUMPH-1 replicates these numbers, it will solidify retatrutide as the most effective pharmaceutical weight loss intervention ever studied

People with diabetes may need special attention in any incretin-related study because changes in appetite, weight, and glucose can interact with existing medicines